Flu prevention - amantadine and oseltamivir (replaced by TA158)
The clinical effectiveness and cost effectiveness of amantadine and oseltamivir for the prophylaxis of influenza
Summary
This guidance has been replaced by TA158 Influenza (prophylaxis) - amantadine, oseltamivir and zanamivir
Guidance documents
Implementing this guidance
Other information
About this guidance
Technology appraisals TA67
Issued: September 2003
How this guidance was produced